WHO ICTRP trial
Post-ESD carbon-ion radiotherapy
JPRN-jRCT1032250012 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCT1032250012 |
|---|---|
| Public title | Post-ESD carbon-ion radiotherapy |
| Scientific title | Phase I study of additional carbon-ion radiotherapy following endoscopic submucosal dissention for esophageal squamous cell carcinoma. - ENCORE trial |
| Primary sponsor | Isozaki Tetsuro |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 1 |
| Conditions | Esophageal Cancer Esophageal Cancer |
| Interventions | Carbon-ion radiotherapy is performed for patients who require additional treatment after ESD for esophageal cancer. |
| Registration date | Apr 22, 2025 |
| Target size | 18 |
| Registry page | jrct.mhlw.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: